Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Importance Patients with Gram-negative bloodstream infections (GN-BSI) are classified as non-immunocompromised (n-IC) or immunocompromised (IC). However, immunosuppressive condition should not be considered univocally. Objective To investigate epidemiological characteristics, management and outcome of GN-BSI in IC and non-IC patients. Methods Retrospective single-center study of hospitalized patients with GN-BSI conducted over a 7-year period. Patients with GN-BSI were divided in: solid organ transplant (SOT) recipients, patients with hematologic malignancy (HM), patients with metastatic solid cancer (mSC), and non-major IC patients (nm-IC). Results 3544 patients analysed: 76.7% nm-IC, 6.5% SOT, 8.0% HM and 8.8% mSC. SOT and HM patients were younger (SOT: 56.6±13.1 years; HM: 56.4±14.5; nm-IC: 72.4±16.1; mSC: 68.6±13.1, p<0.001) and had lower CCI value (SOT: 4.5±2.4; HM: 4.1±2.1; nm-IC: 5.5±2.6; mSC: 9.7±2.5, p<0.001). Urinary tract infection was the most common source of BSI in nm-IC (nm-IC: 50.1%, HM:15%; SOT: 33.3%; mSC: 25.9%, p<0.001), intra-abdominal infection was the more frequent source among SOT and mSC (SOT:42.3%; mSC: 49.3%, nm-IC: 27.8%, HM:29%; p<0.001). Primary BSI was the first cause of GN-BSI in HM (HM: 62.1%; SOT: 18.5%; nm-IC: 17.2%; mSC: 10.6%, p<0.001). The lowest rate of death was observed in SOT and the highest in mSC (SOT 8.2%; nm-IC 13.4%; HM 14.9%; mSC 19.9%, p<0.001). Relapse rate was highest in SOT (SOT: 18.8%; HM: 11.8%; NMIC: 7.2%; aST: 7.1%, p<0.001). Follow-up bloodcultures were associated with a lower mortality only among NMIC (HR=0.317, 95% CI 0.178–0.563, p<0.001) and aST (HR=0.198, 95% CI 0.058–0.673, p=0.010). The role of treatment duration on relapse was not evident in any group, conversely receiving at least 7 days of treatment was associated with a lower risk of 90-day mortality in SOT and HM patients. Conclusions The characteristics and outcome of GN-BSI are peculiar between specific IC categories, therefore a personalized management should be implemented.

Cite

CITATION STYLE

APA

Toschi, A., Pascale, R., Gibertoni, D., Pasquali, R., Grechi, A., Grassi, I., … Giannella, M. (2025). Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study. PLOS ONE, 20(7 July). https://doi.org/10.1371/journal.pone.0327535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free